PMID- 24251013 OWN - NLM STAT- PubMed-not-MEDLINE DCOM- 20131119 LR - 20211021 IS - 2008-5117 (Print) IS - 2008-6830 (Electronic) IS - 2008-5117 (Linking) VI - 5 IP - 2 DP - 2013 TI - Oxidative Versus Thrombotic Stimulation of Platelets Differentially activates Signalling Pathways. PG - 61-5 LID - 10.5681/jcvtr.2013.013 [doi] AB - INTRODUCTION: Atherosclerosis is one of the inflammatory underlying disease associated by oxidative stress and thrombotic agents. This study aimed to evaluate the potential role of cupper oxidized low-density lipoprotein (OxLDL) and thrombin for inducing mitogen activated protein kinases (MAPKs) in platelets. METHODS: Phosphorylation of P38MAPK, Jun N-terminal Kinase (JNK), and Extracellular signal-regulated kinases (ERK1/2) and P-selectin expression were determined in lysates of washed human platelets pretreated with low doses of thrombin and cu2+-OxLDL By Enzyme-linked immunosorbent assay (ELISA). Pharmacological inhibition was performed by SB203580, PD980559 and SP6000125 for P38MAPK, ERK1/2 and JNK activity, respectively. The ratio of phosphorylated to total protein was used for normalizing the phospho proteins contents of cells. RESULTS: OxLDL and thrombin significantly and differentially increased P-selectin expression (P<0.05), P38MAPK (P<0.05) and c-JNK (P<0.05) and ERK1/2 (P<0.05) phosphorylation in platelets. SB 203580 and SP6000125 significantly decreased P-selectin expression in both oxidative (P<0.05) and thrombotic (P<0.05) activated platelets. CONCLUSION: Our results indicated that MAPK inhibitors can reduce atherothrombotic events via alterations in P-selectin expression suggesting that these inhibitors may be useful in the inhibition of atheroma development. FAU - Karimi, Pouran AU - Karimi P AD - Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran. FAU - Rashtchizadeh, Nadereh AU - Rashtchizadeh N LA - eng PT - Journal Article DEP - 20130627 PL - Iran TA - J Cardiovasc Thorac Res JT - Journal of cardiovascular and thoracic research JID - 101528712 PMC - PMC3825387 OTO - NOTNLM OT - Atherosclerosis OT - C-Jun N-terminal Kinase Extracellular OT - P-selectin OT - P38-Mitogen Activated Protein Kinase OT - Signal-regulated Kinase EDAT- 2013/11/20 06:00 MHDA- 2013/11/20 06:01 PMCR- 2013/01/01 CRDT- 2013/11/20 06:00 PHST- 2013/04/17 00:00 [received] PHST- 2013/06/02 00:00 [accepted] PHST- 2013/11/20 06:00 [entrez] PHST- 2013/11/20 06:00 [pubmed] PHST- 2013/11/20 06:01 [medline] PHST- 2013/01/01 00:00 [pmc-release] AID - 10.5681/jcvtr.2013.013 [doi] PST - ppublish SO - J Cardiovasc Thorac Res. 2013;5(2):61-5. doi: 10.5681/jcvtr.2013.013. Epub 2013 Jun 27.